AstraZeneca's three in one inhaler helps COPD patients in trial Medical Dialogues Bureau30 Jan 2018 9:45 AM ISTAstraZeneca said an inhaler for chronic obstructive pulmonary disease delivered improved lung function in a late-stage trial that could challenge...
AstraZeneca steps up China push with new drug joint venture Ruby Khatun Khatun28 Nov 2017 1:50 PM ISTLONDON: Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a...
FDA approves first two-drug HIV regimen from GSK Ruby Khatun Khatun24 Nov 2017 10:37 AM ISTNEW YORK: The U.S. Food and Drug Administration (FDA) on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed...
Bill Gates makes 100 million dollars personal investment to fight Alzheimer Ruby Khatun Khatun15 Nov 2017 10:25 AM ISTLONDON: Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings...
Dynavax hepatitis B vaccine gets FDA nod on third try, shares up Ruby Khatun Khatun11 Nov 2017 9:45 AM ISTDynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr Ruby Khatun Khatun28 Oct 2017 9:46 AM ISTNew Delhi: Drug firm GlaxoSmithKline Pharmaceuticals reported a 31.83 percent rise in standalone net profit to Rs 130.32 crore for the second quarter...
Pfizer to launch consumer health sale in November- sources savita thakur thakur27 Oct 2017 3:21 PM ISTLONDON - Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus...
Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 9:32 AM ISTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...
Lupin appoints Jim Loerop as Chief Corporate Development Officer Ruby Khatun Khatun19 Sept 2017 10:29 AM ISTMumbai: Pharma Major Lupin announced the appointment of Jim Loerop as Chief Corporate Development Officer. Jim will lead Lupin's overall corporate...
USFDA approves GSK three-in-one drug inhaler for COPD Ruby Khatun Khatun19 Sept 2017 9:57 AM ISTGlaxoSmithKline Plc (GSK) and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for the...
Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sept 2017 2:08 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
